ISB News

ISB at Town Hall Seattle on March 27

As an extension of ISB's 13th Annual International Systems Biology Symposium, we are collaborating with Town Hall Seattle to hold a panel discussion. Panelists include ISB president, Dr. Lee Hood; Dr. Tony Blau, of UW's Division of Hematology, Department of Medicine; Dr. Peter Nelson, prostate cancer researcher and oncologist at Fred Hutchinson Cancer Research Center; and moderator Dr. Eric Holland, Senior VP and Director of the Human Biology Division at Fred Hutchinson Cancer Research Center.

Systems Biology and Cancers: Big Data to Personalized Treatment
Date: Thursday, March 27, 2014; 7:30-8:45 p.m.
Location: Downstairs at Town Hall (1119 8th Ave.); enter on Seneca Street
Cost: $5
Buy Tickets Online

 

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.